EP3831422B1 - Vorrichtung zur herstellung einer wasserstoffhaltigen peritonealdialyseflüssigkeit - Google Patents
Vorrichtung zur herstellung einer wasserstoffhaltigen peritonealdialyseflüssigkeit Download PDFInfo
- Publication number
- EP3831422B1 EP3831422B1 EP19861576.7A EP19861576A EP3831422B1 EP 3831422 B1 EP3831422 B1 EP 3831422B1 EP 19861576 A EP19861576 A EP 19861576A EP 3831422 B1 EP3831422 B1 EP 3831422B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- hydrogen
- dialysate
- air supply
- supply module
- peritoneal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 15
- 239000003330 peritoneal dialysis fluid Substances 0.000 title description 2
- 239000001257 hydrogen Substances 0.000 claims description 98
- 229910052739 hydrogen Inorganic materials 0.000 claims description 98
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 88
- 150000002431 hydrogen Chemical class 0.000 claims description 17
- 238000004090 dissolution Methods 0.000 claims description 11
- 210000003200 peritoneal cavity Anatomy 0.000 claims description 7
- 238000000502 dialysis Methods 0.000 description 35
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 238000000034 method Methods 0.000 description 6
- 239000012510 hollow fiber Substances 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 239000002699 waste material Substances 0.000 description 5
- 238000010586 diagram Methods 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 230000035699 permeability Effects 0.000 description 4
- 239000000385 dialysis solution Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000036542 oxidative stress Effects 0.000 description 3
- 239000012466 permeate Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 210000004303 peritoneum Anatomy 0.000 description 2
- -1 polyethylene Polymers 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 229910012375 magnesium hydride Inorganic materials 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/24—Dialysis ; Membrane extraction
- B01D61/243—Dialysis
- B01D61/244—Dialysis comprising multiple dialysis steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
- A61M1/287—Dialysates therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
- A61M1/1656—Apparatus for preparing dialysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/24—Dialysis ; Membrane extraction
- B01D61/243—Dialysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/02—Gases
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2311/00—Details relating to membrane separation process operations and control
- B01D2311/04—Specific process operations in the feed stream; Feed pretreatment
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2313/00—Details relating to membrane modules or apparatus
- B01D2313/90—Additional auxiliary systems integrated with the module or apparatus
Definitions
- Patent Document 1 Japanese Patent No. 4486157
- JP 2016 077675 A discloses a peritoneal dialysis fluid manufacturing device including: a container having hydrogen permeability with a pre-set capacity; dialysis fluid accommodated in the container; a hydrogen water storage tank in which the container in which the dialysis fluid is accommodated is immersed for storing hydrogen water containing hydrogen supplied to the dialysis fluid; a hydrogen water generation device connected to the hydrogen water storage tank for generating the hydrogen water; and a circulation passage for circulating the hydrogen water between the hydrogen water storage tank and the hydrogen water generation device.
- the apparatus for manufacturing hydrogen-containing peritoneal dialysate of the present invention includes: a dialysate bag housing dialysate to be injected into a peritoneal cavity of a patient; and a hydrogen dissolution device interposed between the dialysate bag and the patient and configured to dissolve hydrogen in the dialysate, wherein the hydrogen dissolution device includes: an air supply module connected to the dialysate bag and the patient and configured to dissolve hydrogen in the dialysate; and a hydrogen supply device connected to the air supply module and configured to supply hydrogen to the air supply module.
- the air supply module body 11 is provided with a hydrogen supply port 12, and hydrogen gas is supplied to the outside of the supply tube 10 by the hydrogen supply device 8 through the hydrogen supply port 12.
- the hydrogen supply device 8 is not particularly limited as long as it can supply hydrogen to the air supply module 7.
- a hydrogen generator that electrolyzes water
- a hydrogen generating agent such as magnesium hydride that reacts with water to generate hydrogen
- a hydrogen gas cylinder, and the like can be used.
- the peritoneal dialysis apparatus 40 includes a dialysis apparatus body 41, a supply tube 42 into which the manufactured dialysate 27 is introduced and supplies the dialysate 27 to the dialysis apparatus body 41, and a dialysis catheter 43 connected to the dialysis apparatus body 41 and the peritoneal cavity of a patient 50 and supplying the dialysate 27 to the patient 50. Further, the peritoneal dialysis apparatus 40 includes a waste fluid treatment tank 44 for discarding unused dialysate 27, and a connecting tube 45 connecting the dialysis apparatus body 41 and the waste fluid treatment tank 44.
- the dialysate 27 is supplied to the dialysis apparatus body 41 via the supply tube 42. Then, the dialysate 27 is injected into the peritoneal cavity of the patient 50 via the dialysis catheter 43 by the dialysis apparatus body 41, which is an injection treatment, and the dialysate 27 is drained from the peritoneal cavity, which is a drainage treatment.
- the dialysate 27 supplied with hydrogen is supplied to the peritoneal dialysis apparatus 40, the dialysate 27 thus supplied is supplied from the peritoneal dialysis apparatus 40 to the patient 50, and thus the blood of the patient 50 is purified.
- the hydrogen dissolution device 6 dissolving hydrogen in the dialysate 27 is provided between the dialysate bag 4 and the peritoneal dialysis apparatus 40.
- dialysate 27 including hydrogen while performing peritoneal dialysis, thereby improving convenience of the peritoneal dialysis.
- dialysate 27 excellent in terms of hygiene can be obtained.
- the hydrogen dissolution device 6 only includes the air supply module 7 dissolving hydrogen in the dialysate 27 and the hydrogen supply device 8 supplying hydrogen to the air supply module 7, and thus can supply hydrogen to the dialysate 27 with a simple configuration.
- the air supply module 7 having the supply tube 10 is used to bring hydrogen into contact with the dialysate 27 to dissolve the hydrogen, and thus hydrogen can be efficiently supplied.
- the supply tube 10 is wound in a roll shape and housed in the air supply module body 11. This configuration increases a contact area between the supply tube 10 and hydrogen and allows hydrogen to be supplied to the dialysate 27 even more efficiently.
- an air supply module having a plurality of hollow fibers connected to the dialysate bag 4 and the peritoneal dialysis apparatus 40 may be used.
- the dialysate 27 housed in the dialysate bag 4 is supplied to the inside of the hollow fibers, and hydrogen is supplied to the outside of the hollow fibers by the hydrogen supply device 8.
- the air supply module 7 including the supply tube 10 and the air supply module body 11 shown in FIGS. 2 to 3 is used in terms of efficiency in dissolving hydrogen in the dialysate 27 by increasing an atmospheric pressure of the supplied hydrogen gas in a small amount.
- the dialysate 27 is supplied from the peritoneal dialysis apparatus 40 to the patient 50.
- the dialysate bag 4 may be connected to a tube (catheter) arranged in the patient 50, and the dialysate 27 housed in the dialysate bag 4 may be directly injected into the peritoneal cavity of the patient 50. In such a configuration, the same effect as that of the above embodiment can be obtained.
Landscapes
- Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Water Supply & Treatment (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- External Artificial Organs (AREA)
Claims (1)
- Vorrichtung (1) zur Herstellung einer wasserstoffhaltigen Peritonealdialyseflüssigkeit, wobei die Vorrichtung (1) umfasst:einen Dialyseflüssigkeitsbeutel (4), der eine Dialyseflüssigkeit (27) aufnimmt, die in eine Peritonealhöhle eines Patienten injiziert werden soll; undein Wasserstofflösungsgerät (6), das zwischen dem Dialyseflüssigkeitsbeutel (4) und dem Patienten eingeschoben ist und dazu konfiguriert ist, Wasserstoff in der Dialyseflüssigkeit (27) zu lösen, wobeidas Wasserstofflösungsgerät (6) beinhaltet: Ein Luftzufuhrmodul (7), das mit dem Dialyseflüssigkeitsbeutel (4) und dem Patienten verbunden ist und dazu konfiguriert ist, Wasserstoff in der Dialyseflüssigkeit (27) zu lösen; und ein Wasserstoffzufuhrgerät (8), das mit dem Luftzufuhrmodul (7) verbunden ist und dazu konfiguriert ist, dem Luftzufuhrmodul (7) Wasserstoff zuzuführen,das Luftzufuhrmodul (7) beinhaltet: Einen Zufuhrschlauch (10), der mit dem Dialyseflüssigkeitsbeutel (4) und dem Patienten verbunden ist und dazu konfiguriert ist, dem Patienten die Dialyseflüssigkeit (27) zuzuführen; und ein Luftzufuhrmodulgehäuse (11), das mit dem Wasserstoffzufuhrgerät (8) verbunden ist, den Zufuhrschlauch (10) aufnimmt und dazu konfiguriert ist, dass ihm der Wasserstoff zugeführt wird,der Wasserstoff bei der innerhalb des Zufuhrschlauchs (10) zugeführten Dialyseflüssigkeit (27) der Dialyseflüssigkeit (27) durch Leiten innerhalb des Luftzufuhrmodulgehäuses (11) und außerhalb des Zufuhrschlauchs (10) zugeführt wird, und dadurch gekennzeichnet, dassder Zufuhrschlauch (10) auf eine rollenartige Weise gewickelt wird und in dem Luftzufuhrmodulgehäuse (11) aufgenommen wird.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018176943 | 2018-09-21 | ||
PCT/JP2019/027051 WO2020059259A1 (ja) | 2018-09-21 | 2019-07-08 | 水素含有腹膜透析液の製造装置 |
Publications (3)
Publication Number | Publication Date |
---|---|
EP3831422A1 EP3831422A1 (de) | 2021-06-09 |
EP3831422A4 EP3831422A4 (de) | 2021-09-15 |
EP3831422B1 true EP3831422B1 (de) | 2022-09-21 |
Family
ID=69888648
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19861576.7A Active EP3831422B1 (de) | 2018-09-21 | 2019-07-08 | Vorrichtung zur herstellung einer wasserstoffhaltigen peritonealdialyseflüssigkeit |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP3831422B1 (de) |
JP (1) | JP7104797B2 (de) |
CN (1) | CN112638440A (de) |
WO (1) | WO2020059259A1 (de) |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009125654A (ja) * | 2007-11-22 | 2009-06-11 | Bio Research Inc | 飲料用水素含有水の製造方法 |
JP4967001B2 (ja) | 2009-03-13 | 2012-07-04 | ミズ株式会社 | 水素含有生体適用液の製造方法、及びそのための装置 |
JP2014161605A (ja) | 2013-02-27 | 2014-09-08 | Nippon Torimu:Kk | 水素付加装置および腹膜透析装置 |
CN103432164B (zh) * | 2013-09-11 | 2015-12-09 | 华仁药业股份有限公司 | 腹膜透析液及其制备方法 |
JP5840248B2 (ja) * | 2014-03-19 | 2016-01-06 | 株式会社日本トリム | 透析液の製造装置 |
JP2016077675A (ja) * | 2014-10-20 | 2016-05-16 | 株式会社日本トリム | 腹膜透析液の製造装置 |
CN204563092U (zh) * | 2015-02-11 | 2015-08-19 | 汪玲果 | 腹膜透析装置 |
CN205612789U (zh) * | 2016-01-21 | 2016-10-05 | 李涛 | 一种腹膜透析装置 |
JP5940753B1 (ja) * | 2016-03-07 | 2016-06-29 | 株式会社日本トリム | 水素含有腹膜透析液の製造装置 |
-
2019
- 2019-07-08 EP EP19861576.7A patent/EP3831422B1/de active Active
- 2019-07-08 JP JP2020548021A patent/JP7104797B2/ja active Active
- 2019-07-08 WO PCT/JP2019/027051 patent/WO2020059259A1/ja unknown
- 2019-07-08 CN CN201980056760.5A patent/CN112638440A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2020059259A1 (ja) | 2020-03-26 |
CN112638440A (zh) | 2021-04-09 |
EP3831422A1 (de) | 2021-06-09 |
JP7104797B2 (ja) | 2022-07-21 |
EP3831422A4 (de) | 2021-09-15 |
JPWO2020059259A1 (ja) | 2021-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104968376B (zh) | 用于递送肾替代疗法的流体回路 | |
AU2010222294B2 (en) | Process and apparatus for producing hydrogen-containing biocompatible solution | |
KR970703175A (ko) | 용액의 제조 및 저장 방법(Method of Manufacturing and Storing Solutions) | |
JP2012005670A (ja) | 血液透析装置 | |
EP2881167A1 (de) | Flüssigkeitsversorgungsvorrichtung und biologische reinigungsvorrichtung | |
JP2014161605A (ja) | 水素付加装置および腹膜透析装置 | |
WO2016063480A1 (ja) | 腹膜透析液の製造装置 | |
EP3831422B1 (de) | Vorrichtung zur herstellung einer wasserstoffhaltigen peritonealdialyseflüssigkeit | |
JP6596199B2 (ja) | 水素水の製造方法および水素水製造装置 | |
JP5336926B2 (ja) | 精製水の製造方法及び精製水の製造装置 | |
JP3845110B2 (ja) | 医療用滅菌包装における滅菌方法 | |
US20050051472A1 (en) | Dialyzer reprocessing system | |
EP3831423B1 (de) | Vorrichtung zur herstellung einer wasserstoffhaltigen peritonealdialyseflüssigkeit | |
EP3842082B1 (de) | Vorrichtung zur herstellung einer dialyselösung | |
US7077961B2 (en) | Apparatus for extracorporeal blood or plasma treatment comprising a wet semi-permeable membrane and methods for making the same | |
JP7022088B2 (ja) | 水素付加装置及び水素付加方法 | |
JP7123212B1 (ja) | 精製水製造装置 | |
JP2002058725A (ja) | 炭酸水製造方法 | |
KR100495313B1 (ko) | 인공 신장기용 순수 배관 라인 소독 방법 | |
KR100495314B1 (ko) | 인공 신장기의 투석용액 공급관 소독 방법 | |
CN220917807U (zh) | 一种浸泡容器 | |
CN219681146U (zh) | 一种辐照血输血袋 | |
JP3081405U (ja) | 消毒機能付き腎臓透析機の構造 | |
JP2019166453A (ja) | 混合ガスの製造方法、混合ガス製造装置および混合ガス供給システム | |
JPH04292171A (ja) | 膜型人工肺の保存方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20210301 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20210816 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: B01D 61/24 20060101ALI20210810BHEP Ipc: A61P 7/08 20060101ALI20210810BHEP Ipc: A61M 1/16 20060101ALI20210810BHEP Ipc: A61M 1/28 20060101AFI20210810BHEP |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20220506 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602019019897 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1519648 Country of ref document: AT Kind code of ref document: T Effective date: 20221015 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: FP |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: TRGR |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220921 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221221 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220921 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220921 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220921 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1519648 Country of ref document: AT Kind code of ref document: T Effective date: 20220921 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220921 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221222 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220921 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220921 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230123 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220921 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220921 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220921 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220921 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220921 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230121 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220921 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602019019897 Country of ref document: DE |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230524 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220921 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220921 |
|
26N | No opposition filed |
Effective date: 20230622 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220921 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20230719 Year of fee payment: 5 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20230724 Year of fee payment: 5 Ref country code: GB Payment date: 20230721 Year of fee payment: 5 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20230719 Year of fee payment: 5 Ref country code: FR Payment date: 20230726 Year of fee payment: 5 Ref country code: DE Payment date: 20230719 Year of fee payment: 5 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220921 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220921 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20230731 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230708 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230708 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230731 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230731 |